価格表

在庫・価格 : 2024年04月27日 10時11分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Adiponectin, Human, ELISA Kit (96well)
データシート
RD195023100 BLMバイオベンダー ラボラトリー
BioVendor Laboratory Medicine, Inc.
1 kit ¥108,000
(未発注)
追加

在庫・価格 : 2024年04月27日 10時11分 現在

Adiponectin, Human, ELISA Kit (96well)

  • 商品コード:RD195023100
  • メーカー:BLM
  • 包装:1kit
  • 価格: ¥108,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Stejskal D et al. Adiponectin in patients with various stages of coronary heart disease - comparison of its concentration in coronary arteries and peripheral venous circulation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003 Dec;147(2):161-6
Stejskal D et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
2 Stejskal D et al. Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003 Dec;147(2):167-72
Stejskal D et al
2003/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
3 Pilz S et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J. Clin. Endocrinol. Metab. 2005 Aug;90(8):4792-6
Pilz S et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
4 Pilz S et al. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study. Clin. Chim. Acta 2006 Feb;364(1-2):251-5
Pilz S et al
2006/01/01
PubMed
5 Bobbert T et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005 Sep;54(9):2712-9
Bobbert T et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
6 Avignon A et al. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care 2005 Sep;28(9):2176-80
Avignon A et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
7 Stejskal D et al. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005 Jun;149(1):93-9
Stejskal D et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
8 Tsioufis C et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am. J. Cardiol. 2005 Oct;96(7):946-51
Tsioufis C et al
2005/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
9 Spranger J et al. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006 Jan;55(1):141-7
Spranger J et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
10 M旦hlig M et al. Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men. J. Clin. Endocrinol. Metab. 2006 Mar;91(3):964-7
M旦hlig M et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
11 Chu MC et al. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am. J. Obstet. Gynecol. 2006 Jan;194(1):100-4
Chu MC et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
12 Karaduman M et al. Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clin. Endocrinol. (Oxf) 2006 Feb;64(2):196-202
Karaduman M et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
13 von Eynatten M et al. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin. Chem. 2006 May;52(5):853-9
von Eynatten M et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
14 Weickert MO et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006 Apr;29(4):775-80
Weickert MO et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
15 Otto C et al. Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels. J. Endocrinol. Invest. 2006 Mar;29(3):231-6
Otto C et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
16 Mojiminiyi OA et al. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Int J Obes (Lond) 2007 Feb;31(2):213-20
Mojiminiyi OA et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
17 Dieplinger B et al. Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease. Clin. Chem. Lab. Med. 2006;44(7):830-3
Dieplinger B et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
18 Shin MJ et al. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant. Metab. Clin. Exp. 2006 Jul;55(7):918-22
Shin MJ et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
19 Risch L et al. Evaluation of two fully automated novel enzyme-linked immunosorbent assays for the determination of human adiponectin in serum. Clin. Chim. Acta 2006 Nov;373(1-2):121-6
Risch L et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
20 Giri S et al. AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab (Lond) 2006;3:31
Giri S et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
21 Pilz S et al. Adiponectin and mortality in patients undergoing coronary angiography. J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4277-86
Pilz S et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
22 Stejskal D et al. Adiponectin added into the plasma of healthy probands does not affect platelet aggregability. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006 Jul;150(1):89-90
Stejskal D et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
23 Risch L et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin. Chim. Acta 2007 Feb;376(1-2):108-13
Risch L et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
24 Baranova A et al. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obes Surg 2006 Sep;16(9):1118-25
Baranova A et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
25 Bersinger NA et al. Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles. Gynecol. Endocrinol. 2006 Sep;22(9):479-83
Bersinger NA et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
26 Senolt L et al. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006 Sep;35(5-6):247-52
Senolt L et al
2006/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
27 Dieplinger B et al. Association of adiponectin and amino terminal proBNP in peripheral arterial disease. Clin. Chim. Acta 2007 Feb;377(1-2):192-7
Dieplinger B et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
28 Bobbert T et al. Adiponectin oligomers in human serum during acute and chronic exercise: relation to lipid metabolism and insulin sensitivity. Int J Sports Med 2007 Jan;28(1):1-8
Bobbert T et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
29 Delfini E et al. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metab. Clin. Exp. 2007 Jan;56(1):30-6
Delfini E et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
30 Shin MJ et al. Serum retinol binding protein 4 levels are associated with serum adiponectin levels in non-diabetic, non-obese subjects with hypercholesterolemia. Clin. Chim. Acta 2007 Mar;378(1-2):227-9
Shin MJ et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
31 Moro C et al. Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue. Diabetologia 2007 May;50(5):1038-47
Moro C et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
32 Catal叩n V et al. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clin. Endocrinol. (Oxf) 2007 Apr;66(4):598-601
Catal叩n V et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
33 Vitkova M et al. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J. Clin. Endo
Vitkova M et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
34 Otto C et al. Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia. Acta Diabetol 2007 Jun;44(2):65-8
Otto C et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
35 Saely CH et al. Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis. Clin. Chim. Acta 2007 Aug;383(1-2):97-102
Saely CH et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
36 G坦mez-Ambrosi J et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J. Clin. Endocrinol. Metab. 2007 Sep;92(9):3719-27
G坦mez-Ambrosi J et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
37 Golledge J et al. Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis 2008 Mar;197(1):428-34
Golledge J et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
38 Avignon A et al. Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients. Diabetes Care 2007 Nov;30(11):2934-9
Avignon A et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
39 Vaverkova H et al. Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia. Atherosclerosis 2008 Apr;197(2):725-31
Vaverkova H et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
40 Catal叩n V et al. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin. Endocrinol. (Oxf) 2008 Feb;68(2):213-9
Catal叩n V et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
41 Cabr辿 A et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J. Intern. Med. 2007 Oct;262(4):496-503
Cabr辿 A et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
42 Krusinov叩 E et al. Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects. Eur. J. Endocrinol. 2007 Oct;157(4):443-9
Krusinov叩 E et al
2007/01/01
PubMed
43 Lamounier-Zepter V et al. Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice. Mol. Cell. Endocrinol. 2008 Jan;280(1-2):39-46
Lamounier-Zepter V et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
44 Catal叩n V et al. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 2007 Nov;17(11):1464-74
Catal叩n V et al
2007/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
45 Benedict C et al. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J. Clin. Endocrinol. Metab. 2008 Apr;93(4):1339-44
Benedict C et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
46 Schnabel R et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur. Heart J. 2008 Mar;29(5):649-57
Schnabel R et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
47 Serelis J et al. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin. Rheumatol. 2008 Jun;27(6):795-7
Serelis J et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
48 Chalvatzas N et al. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertil. Steril. 2009 Apr;91(4):1189-94
Chalvatzas N et al
2009/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
49 Polak J et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur. J. Endocrinol. 2008 Apr;158(4):533-41
Polak J et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
50 Catal叩n V et al. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes Surg 2008 Jun;18(6):695-701
Catal叩n V et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
51 Marinoni E et al. Effects of prenatal betamethasone administration on leptin and adiponectin concentrations in maternal and fetal circulation. Am. J. Obstet. Gynecol. 2008 Aug;199(2):141.e1-6
Marinoni E et al
2008/01/01
Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate PubMed
52 Annuzzi G et al. Type 2 diabetes mellitus is characterized by reduced postprandial adiponectin response: a possible link with diabetic postprandial dyslipidemia. Metab. Clin. Exp. 2010 Apr;59(4):567-74
Annuzzi G et al
2010/01/01
PubMed
53 Mente A et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010 Jul;33(7):1629-34
Mente A et al
2010/01/01
PubMed
54 Khosrowbeygi A et al. Maternal serum levels of adiponectin in preeclampsia. J Ayub Med Coll Abbottabad ;21(3):79-82
Khosrowbeygi A et al
PubMed
55 Antonopoulos AS et al. Genetic variability on adiponectin gene affects myocardial infarction risk: the role of endothelial dysfunction. Int. J. Cardiol. 2013 Sep;168(1):326-30
Antonopoulos AS et al
2013/01/01
PubMed
56 Arzola-Paniagua MA et al. Efficacy of an orlistat-resveratrol combination for weight loss in subjects with obesity: A randomized controlled trial. Obesity (Silver Spring) 2016 07;24(7):1454-63
Arzola-Paniagua MA et al
2016/01/01
PubMed
57 Gumanova NG et al. Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. Biomarkers ;22(3-4):239-245
Gumanova NG et al
PubMed
58 Jang HB et al. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metab. Clin. Exp. 2017 08;73:100-108
Jang HB et al
2017/01/01
PubMed
59 Kajiya T et al. Paradoxical effects of adiponectin level on plaque vulnerability and clinical outcomes after coronary revascularization. Int. J. Cardiol. 2013 Oct;168(5):4796-8
Kajiya T et al
2013/01/01
PubMed
60 Khosrowbeygi A et al. Tumor necrosis factor- α, adiponectin and their ratio in gestational diabetes mellitus. Caspian J Intern Med 2018;9(1):71-79
Khosrowbeygi A et al
2018/01/01
PubMed
61 Koleva DI et al. Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome. Arch. Physiol. Biochem. 2016 Oct;122(4):223-227
Koleva DI et al
2016/01/01
PubMed
62 Lu Y et al. Neuropeptide Y associated with asthma in young adults. Neuropeptides 2016 Oct;59:117-121
Lu Y et al
2016/01/01
PubMed
63 Luque-Ram鱈rez M et al. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum. Reprod. 2013 Jul;28(7):1908-18
Luque-Ram鱈rez M et al
2013/01/01
PubMed
64 Mangge H et al. Serum neopterin is not increased in obese juveniles. J Obes 2011;2011:946795
Mangge H et al
2011/01/01
PubMed
65 Novotny D et al. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res 2014;63(2):219-28
Novotny D et al
2014/01/01
PubMed
66 Oranskiy SP et al. Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis. Croat. Med. J. 2012 Aug;53(4):350-6
Oranskiy SP et al
2012/01/01
PubMed
67 Popova P et al. A Randomised, Controlled Study of Different Glycaemic Targets during Gestational Diabetes Treatment: Effect on the Level of Adipokines in Cord Blood and ANGPTL4 Expression in Human Umbilical Vein Endothelial Cells. Int J Endocrinol 2018;20
Popova P et al
2018/01/01
PubMed
68 Rubino E et al. Investigating the role of adipokines in chronic migraine. Cephalalgia 2017 Oct;37(11):1067-1073
Rubino E et al
2017/01/01
PubMed
69 Sahebkar A et al. Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis 2013 Sep;230(1):110-20
Sahebkar A et al
2013/01/01
PubMed
70 Tvarijonaviciute A et al. Effects of thyroxin therapy on different analytes related to obesity and inflammation in dogs with hypothyroidism. Vet J 2013 Apr;196(1):71-5
Tvarijonaviciute A et al
2013/01/01
PubMed
71 van Gemert WA et al. Association between changes in fat distribution and biomarkers for breast cancer. Endocr. Relat. Cancer 2017 06;24(6):297-305
van Gemert WA et al
2017/01/01
PubMed
72 Vaverkova H et al. Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjects. Clin Biochem 2013 Jun;46(9):766-71
Vaverkova H et al
2013/01/01
PubMed
73 Leutner M et al. Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects. Int J Endocrinol 2018;2018:5406128
Leutner M et al
2018/01/01
PubMed
74 Behrouz V et al. Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Middle East J Dig Dis 2017 Jul;9(3):150-157
Behrouz V et al
2017/01/01
PubMed
75 Ozmen HK et al. Carnitine and Adiponectin Levels in Breast Cancer after Radiotherapy. Open Med (Wars) 2017;12:189-194
Ozmen HK et al
2017/01/01
PubMed
  • No.: 1
  • 文献情報:
    Stejskal D et al. Adiponectin in patients with various stages of coronary heart disease - comparison of its concentration in coronary arteries and peripheral venous circulation. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003 Dec;147(2):161-6
    Stejskal D et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Stejskal D et al. Adiponectin concentrations as a criterion of metabolic control in persons with type 2 diabetes mellitus? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003 Dec;147(2):167-72
    Stejskal D et al
    2003/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Pilz S et al. Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin. J. Clin. Endocrinol. Metab. 2005 Aug;90(8):4792-6
    Pilz S et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Pilz S et al. Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study. Clin. Chim. Acta 2006 Feb;364(1-2):251-5
    Pilz S et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Bobbert T et al. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005 Sep;54(9):2712-9
    Bobbert T et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Avignon A et al. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care 2005 Sep;28(9):2176-80
    Avignon A et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Stejskal D et al. High adiponectin and TNF-alpha levels in moderate drinkers suffering from liver steatosis: comparison with non drinkers suffering from similar hepatopathy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005 Jun;149(1):93-9
    Stejskal D et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Tsioufis C et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am. J. Cardiol. 2005 Oct;96(7):946-51
    Tsioufis C et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Spranger J et al. Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006 Jan;55(1):141-7
    Spranger J et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    M旦hlig M et al. Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men. J. Clin. Endocrinol. Metab. 2006 Mar;91(3):964-7
    M旦hlig M et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Chu MC et al. Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin. Am. J. Obstet. Gynecol. 2006 Jan;194(1):100-4
    Chu MC et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Karaduman M et al. Tissue levels of adiponectin, tumour necrosis factor-alpha, soluble intercellular adhesion molecule-1 and heart-type fatty acid-binding protein in human coronary atherosclerotic plaques. Clin. Endocrinol. (Oxf) 2006 Feb;64(2):196-202
    Karaduman M et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    von Eynatten M et al. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin. Chem. 2006 May;52(5):853-9
    von Eynatten M et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Weickert MO et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006 Apr;29(4):775-80
    Weickert MO et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Otto C et al. Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels. J. Endocrinol. Invest. 2006 Mar;29(3):231-6
    Otto C et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Mojiminiyi OA et al. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Int J Obes (Lond) 2007 Feb;31(2):213-20
    Mojiminiyi OA et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Dieplinger B et al. Hypoadiponectinemia is associated with symptomatic atherosclerotic peripheral arterial disease. Clin. Chem. Lab. Med. 2006;44(7):830-3
    Dieplinger B et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Shin MJ et al. Insulin resistance, adipokines, and oxidative stress in nondiabetic, hypercholesterolemic patients: leptin as an 8-epi-prostaglandin F2alpha determinant. Metab. Clin. Exp. 2006 Jul;55(7):918-22
    Shin MJ et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Risch L et al. Evaluation of two fully automated novel enzyme-linked immunosorbent assays for the determination of human adiponectin in serum. Clin. Chim. Acta 2006 Nov;373(1-2):121-6
    Risch L et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Giri S et al. AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab (Lond) 2006;3:31
    Giri S et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Pilz S et al. Adiponectin and mortality in patients undergoing coronary angiography. J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4277-86
    Pilz S et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Stejskal D et al. Adiponectin added into the plasma of healthy probands does not affect platelet aggregability. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006 Jul;150(1):89-90
    Stejskal D et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Risch L et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin. Chim. Acta 2007 Feb;376(1-2):108-13
    Risch L et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Baranova A et al. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance. Obes Surg 2006 Sep;16(9):1118-25
    Baranova A et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Bersinger NA et al. Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles. Gynecol. Endocrinol. 2006 Sep;22(9):479-83
    Bersinger NA et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Senolt L et al. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006 Sep;35(5-6):247-52
    Senolt L et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Dieplinger B et al. Association of adiponectin and amino terminal proBNP in peripheral arterial disease. Clin. Chim. Acta 2007 Feb;377(1-2):192-7
    Dieplinger B et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Bobbert T et al. Adiponectin oligomers in human serum during acute and chronic exercise: relation to lipid metabolism and insulin sensitivity. Int J Sports Med 2007 Jan;28(1):1-8
    Bobbert T et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Delfini E et al. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metab. Clin. Exp. 2007 Jan;56(1):30-6
    Delfini E et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Shin MJ et al. Serum retinol binding protein 4 levels are associated with serum adiponectin levels in non-diabetic, non-obese subjects with hypercholesterolemia. Clin. Chim. Acta 2007 Mar;378(1-2):227-9
    Shin MJ et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Moro C et al. Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue. Diabetologia 2007 May;50(5):1038-47
    Moro C et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Catal叩n V et al. The obestatin receptor (GPR39) is expressed in human adipose tissue and is down-regulated in obesity-associated type 2 diabetes mellitus. Clin. Endocrinol. (Oxf) 2007 Apr;66(4):598-601
    Catal叩n V et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Vitkova M et al. Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity. J. Clin. Endo
    Vitkova M et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Otto C et al. Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia. Acta Diabetol 2007 Jun;44(2):65-8
    Otto C et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Saely CH et al. Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis. Clin. Chim. Acta 2007 Aug;383(1-2):97-102
    Saely CH et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    G坦mez-Ambrosi J et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J. Clin. Endocrinol. Metab. 2007 Sep;92(9):3719-27
    G坦mez-Ambrosi J et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Golledge J et al. Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. Atherosclerosis 2008 Mar;197(1):428-34
    Golledge J et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Avignon A et al. Osteoprotegerin: a novel independent marker for silent myocardial ischemia in asymptomatic diabetic patients. Diabetes Care 2007 Nov;30(11):2934-9
    Avignon A et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Vaverkova H et al. Positive association of adiponectin with soluble vascular cell adhesion molecule sVCAM-1 levels in patients with vascular disease or dyslipidemia. Atherosclerosis 2008 Apr;197(2):725-31
    Vaverkova H et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Catal叩n V et al. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation. Clin. Endocrinol. (Oxf) 2008 Feb;68(2):213-9
    Catal叩n V et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Cabr辿 A et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J. Intern. Med. 2007 Oct;262(4):496-503
    Cabr辿 A et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Krusinov叩 E et al. Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects. Eur. J. Endocrinol. 2007 Oct;157(4):443-9
    Krusinov叩 E et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Lamounier-Zepter V et al. Adrenocortical changes and arterial hypertension in lipoatrophic A-ZIP/F-1 mice. Mol. Cell. Endocrinol. 2008 Jan;280(1-2):39-46
    Lamounier-Zepter V et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Catal叩n V et al. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 2007 Nov;17(11):1464-74
    Catal叩n V et al
    2007/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Benedict C et al. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J. Clin. Endocrinol. Metab. 2008 Apr;93(4):1339-44
    Benedict C et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 46
  • 文献情報:
    Schnabel R et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur. Heart J. 2008 Mar;29(5):649-57
    Schnabel R et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 47
  • 文献情報:
    Serelis J et al. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin. Rheumatol. 2008 Jun;27(6):795-7
    Serelis J et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 48
  • 文献情報:
    Chalvatzas N et al. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertil. Steril. 2009 Apr;91(4):1189-94
    Chalvatzas N et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 49
  • 文献情報:
    Polak J et al. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur. J. Endocrinol. 2008 Apr;158(4):533-41
    Polak J et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 50
  • 文献情報:
    Catal叩n V et al. Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes Surg 2008 Jun;18(6):695-701
    Catal叩n V et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 51
  • 文献情報:
    Marinoni E et al. Effects of prenatal betamethasone administration on leptin and adiponectin concentrations in maternal and fetal circulation. Am. J. Obstet. Gynecol. 2008 Aug;199(2):141.e1-6
    Marinoni E et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Serum,Plasma-EDTA,Plasma-Heparin,Plasma-Citrate
  • 参照:
    PubMed
  • No.: 52
  • 文献情報:
    Annuzzi G et al. Type 2 diabetes mellitus is characterized by reduced postprandial adiponectin response: a possible link with diabetic postprandial dyslipidemia. Metab. Clin. Exp. 2010 Apr;59(4):567-74
    Annuzzi G et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 53
  • 文献情報:
    Mente A et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010 Jul;33(7):1629-34
    Mente A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 54
  • 文献情報:
    Khosrowbeygi A et al. Maternal serum levels of adiponectin in preeclampsia. J Ayub Med Coll Abbottabad ;21(3):79-82
    Khosrowbeygi A et al
  • 備考:
  • 参照:
    PubMed
  • No.: 55
  • 文献情報:
    Antonopoulos AS et al. Genetic variability on adiponectin gene affects myocardial infarction risk: the role of endothelial dysfunction. Int. J. Cardiol. 2013 Sep;168(1):326-30
    Antonopoulos AS et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 56
  • 文献情報:
    Arzola-Paniagua MA et al. Efficacy of an orlistat-resveratrol combination for weight loss in subjects with obesity: A randomized controlled trial. Obesity (Silver Spring) 2016 07;24(7):1454-63
    Arzola-Paniagua MA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 57
  • 文献情報:
    Gumanova NG et al. Ratios of leptin to insulin and adiponectin to endothelin are sex-dependently associated with extent of coronary atherosclerosis. Biomarkers ;22(3-4):239-245
    Gumanova NG et al
  • 備考:
  • 参照:
    PubMed
  • No.: 58
  • 文献情報:
    Jang HB et al. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metab. Clin. Exp. 2017 08;73:100-108
    Jang HB et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 59
  • 文献情報:
    Kajiya T et al. Paradoxical effects of adiponectin level on plaque vulnerability and clinical outcomes after coronary revascularization. Int. J. Cardiol. 2013 Oct;168(5):4796-8
    Kajiya T et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 60
  • 文献情報:
    Khosrowbeygi A et al. Tumor necrosis factor- α, adiponectin and their ratio in gestational diabetes mellitus. Caspian J Intern Med 2018;9(1):71-79
    Khosrowbeygi A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 61
  • 文献情報:
    Koleva DI et al. Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome. Arch. Physiol. Biochem. 2016 Oct;122(4):223-227
    Koleva DI et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 62
  • 文献情報:
    Lu Y et al. Neuropeptide Y associated with asthma in young adults. Neuropeptides 2016 Oct;59:117-121
    Lu Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 63
  • 文献情報:
    Luque-Ram鱈rez M et al. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum. Reprod. 2013 Jul;28(7):1908-18
    Luque-Ram鱈rez M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 64
  • 文献情報:
    Mangge H et al. Serum neopterin is not increased in obese juveniles. J Obes 2011;2011:946795
    Mangge H et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 65
  • 文献情報:
    Novotny D et al. Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res 2014;63(2):219-28
    Novotny D et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 66
  • 文献情報:
    Oranskiy SP et al. Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis. Croat. Med. J. 2012 Aug;53(4):350-6
    Oranskiy SP et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 67
  • 文献情報:
    Popova P et al. A Randomised, Controlled Study of Different Glycaemic Targets during Gestational Diabetes Treatment: Effect on the Level of Adipokines in Cord Blood and ANGPTL4 Expression in Human Umbilical Vein Endothelial Cells. Int J Endocrinol 2018;20
    Popova P et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 68
  • 文献情報:
    Rubino E et al. Investigating the role of adipokines in chronic migraine. Cephalalgia 2017 Oct;37(11):1067-1073
    Rubino E et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 69
  • 文献情報:
    Sahebkar A et al. Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis 2013 Sep;230(1):110-20
    Sahebkar A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 70
  • 文献情報:
    Tvarijonaviciute A et al. Effects of thyroxin therapy on different analytes related to obesity and inflammation in dogs with hypothyroidism. Vet J 2013 Apr;196(1):71-5
    Tvarijonaviciute A et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 71
  • 文献情報:
    van Gemert WA et al. Association between changes in fat distribution and biomarkers for breast cancer. Endocr. Relat. Cancer 2017 06;24(6):297-305
    van Gemert WA et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 72
  • 文献情報:
    Vaverkova H et al. Positive association of adiponectin with soluble thrombomodulin, von Willebrand factor and soluble VCAM-1 in dyslipidemic subjects. Clin Biochem 2013 Jun;46(9):766-71
    Vaverkova H et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 73
  • 文献情報:
    Leutner M et al. Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects. Int J Endocrinol 2018;2018:5406128
    Leutner M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 74
  • 文献情報:
    Behrouz V et al. Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial. Middle East J Dig Dis 2017 Jul;9(3):150-157
    Behrouz V et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 75
  • 文献情報:
    Ozmen HK et al. Carnitine and Adiponectin Levels in Breast Cancer after Radiotherapy. Open Med (Wars) 2017;12:189-194
    Ozmen HK et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed